Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Alzheimer's Disease

Free Subscription 27.06.2022 1 Acta Neuropathol 1 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 4 Ann Neurol 1 Biochemistry 5 Biol Psychiatry 1 Brain Res 2 Curr Alzheimer Res 1 Exp Neurol 18 J Alzheimers Dis 2 J Neurol 1 J Neurosci 1 JAMA 1 Nat Rev Neurosci 1 Neurobiol Aging 3 Neurobiol Dis 1 Neurology 1 Neuropsychology 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. WANG SJ, Guo Y, Ervin JF, Lusk JB, et al
   Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old.
   Acta Neuropathol. 2022;144:45-57.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. WINGO TS, Gerasimov ES, Canon SM, Lah JJ, et al
   Alzheimer's disease genetic burden is associated with mid-life depression among persons with normal cognition.
   Alzheimers Dement. 2022 Jun 21. doi: 10.1002/alz.12716.
   PubMed         Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

3. XU X, Ruan X, Ju R, Wang Z, et al
   Progesterone Receptor Membrane Component-1 May Promote Survival of Human Brain Microvascular Endothelial Cells in Alzheimer's Disease.
   Am J Alzheimers Dis Other Demen. 2022;37:15333175221109749.
   PubMed         Abstract available
   
   

   
   Ann Neurol

4. OECKL P, Wagemann O, Halbgebauer S, Anderl-Straub S, et al
   Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.
   Ann Neurol. 2022;92:6-10.
   PubMed         Abstract available
   
   
5. BUCKLEY RF, O'Donnell A, McGrath ER, Jacobs HIL, et al
   Menopause status moderates sex differences in tau burden: a Framingham PET Study.
   Ann Neurol. 2022 Apr 26. doi: 10.1002/ana.26382.
   PubMed         Abstract available
   
   
6. CASULA EP, Pellicciari MC, Bonni S, Borghi I, et al
   Decreased frontal gamma activity in Alzheimer's disease patients.
   Ann Neurol. 2022 Jun 17. doi: 10.1002/ana.26444.
   PubMed         Abstract available
   
   
7. HEAD E, Zetterberg H
   Commentary on Oeckl et al., "Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181".
   Ann Neurol. 2022;92:3-5.
   PubMed        
   
   

   
   Biochemistry

8. RAJPOOT J, Crooks EJ, Irizarry BA, Amundson A, et al
   Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Abeta40-Iowa and Abeta40-Dutch Peptides.
   Biochemistry. 2022;61:1181-1198.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

9. NUMBERS K
   Emerging Neuropsychiatric Symptoms May Represent an Early Manifestation of Preclinical Alzheimer's Disease.
   Biol Psychiatry. 2022;92:e1-e3.
   PubMed        
   
   
10. WOJDA U
    The Perspective of Exosomal MicroRNAs as Biomarkers for Preclinical Alzheimer's Disease.
    Biol Psychiatry. 2022;92:5-7.
    PubMed        
    
    
11. YANG HS
    Human Genetics Clarifies the Relationship Between Depression and Alzheimer's Disease.
    Biol Psychiatry. 2022;92:2-4.
    PubMed        
    
    
12. BIRBA A, Santamaria-Garcia H, Prado P, Cruzat J, et al
    Allostatic-Interoceptive Overload in Frontotemporal Dementia.
    Biol Psychiatry. 2022;92:54-67.
    PubMed         Abstract available
    
    
13. LIN H, Tang M, Ji C, Girardi P, et al
    BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance.
    Biol Psychiatry. 2022;92:10-24.
    PubMed         Abstract available
    
    

    
    Brain Res

14. FU X, Liu J, Xie J, Chen G, et al
    Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice.
    Brain Res. 2022;1790:147983.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

15. SOHRABI M, Sahu B, Kaur H, Hasler W, et al
    Gastrointestinal Changes and Alzheimer's Disease.
    Curr Alzheimer Res. 2022 Jun 17. pii: CAR-EPUB-124584.
    PubMed         Abstract available
    
    
16. MATTEO CR, Paolo V, Nicoletta A, Luca M, et al
    Vascular lesions and brain atrophy in Alzheimer's, vascular and mixed dementia: an optimized 3T MRI protocol reveals distinctive radiological profiles.
    Curr Alzheimer Res. 2022 Jun 20. pii: CAR-EPUB-124629.
    PubMed         Abstract available
    
    

    
    Exp Neurol

17. HUSSEIN A, Tielemans A, Baxter MG, Benson DL, et al
    Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
    Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

18. MCGRATH ER, Beiser AS, O'Donnell A, Yang Q, et al
    Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    J Alzheimers Dis. 2022;87:1517-1526.
    PubMed         Abstract available
    
    
19. CASTILLO-PASSI RI, Vergara RC, Rogers NK, Ponce DP, et al
    Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment.
    J Alzheimers Dis. 2022;87:1695-1711.
    PubMed         Abstract available
    
    
20. ZHAO X, Du W, Jiang J, Han Y, et al
    Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
    J Alzheimers Dis. 2022;87:1581-1589.
    PubMed         Abstract available
    
    
21. SHAW BC, Snider HC, Turner AK, Zajac DJ, et al
    An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain.
    J Alzheimers Dis. 2022;87:1647-1657.
    PubMed         Abstract available
    
    
22. MCCARTER SJ, Lesnick TG, Lowe VJ, Rabinstein AA, et al
    Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    J Alzheimers Dis. 2022;87:1537-1547.
    PubMed         Abstract available
    
    
23. GAN J, Liu S, Chen Z, Yang Y, et al
    Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;1.
    PubMed         Abstract available
    
    
24. ZHU LY, Shi L, Luo Y, Leung J, et al
    Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215189. doi: 10.3233/JAD-215189.
    PubMed         Abstract available
    
    
25. JESTER H, Gosrani S, Ding H, Zhou X, et al
    Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215303. doi: 10.3233/JAD-215303.
    PubMed         Abstract available
    
    
26. LEONHARDI J, Barthel H, Speerforck S, Dietzel J, et al
    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215619. doi: 10.3233/JAD-215619.
    PubMed         Abstract available
    
    
27. KOBAYASHI M, Yamada Y, Shinkawa K, Nemoto M, et al
    Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215714. doi: 10.3233/JAD-215714.
    PubMed         Abstract available
    
    
28. MIELKE MM, Ransom JE, Mandrekar J, Turcano P, et al
    Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220159. doi: 10.3233/JAD-220159.
    PubMed         Abstract available
    
    
29. WEISSBERGER GH, Samek A, Mosqueda L, Nguyen AL, et al
    Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220187. doi: 10.3233/JAD-220187.
    PubMed         Abstract available
    
    
30. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 11. pii: JAD220292. doi: 10.3233/JAD-220292.
    PubMed         Abstract available
    
    
31. BUKHBINDER AS, Ling Y, Hasan O, Jiang X, et al
    Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220361. doi: 10.3233/JAD-220361.
    PubMed         Abstract available
    
    
32. TIAN J, Wang T, Jia K, Guo L, et al
    Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220447. doi: 10.3233/JAD-220447.
    PubMed         Abstract available
    
    
33. SARTO J, Maya G, Molina-Porcel L, Balasa M, et al
    Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank.
    J Alzheimers Dis. 2022;87:1659-1669.
    PubMed         Abstract available
    
    
34. BOMMARITO G, Garibotto V, Frisoni GB, Ribaldi F, et al
    The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging.
    J Alzheimers Dis. 2022;87:1483-1490.
    PubMed         Abstract available
    
    
35. LIBON DJ, Swenson R, Lamar M, Price CC, et al
    The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions.
    J Alzheimers Dis. 2022;87:1419-1432.
    PubMed         Abstract available
    
    

    
    J Neurol

36. ROSENBLUM Y, Shiner T, Bregman N, Fahoum F, et al
    Event-related oscillations differentiate between cognitive, motor and visual impairments.
    J Neurol. 2022;269:3529-3540.
    PubMed         Abstract available
    
    
37. LAFORCE RJ, Dallaire-Theroux C, Racine AM, Dent G, et al
    Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.
    J Neurol. 2022;269:3579-3587.
    PubMed         Abstract available
    
    

    
    J Neurosci

38. WANG LH, Lin CY, Lin YM, Buee L, et al
    Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
    J Neurosci. 2022;42:5102-5114.
    PubMed         Abstract available
    
    

    
    JAMA

39. RUBIN R
    New Test to Help Diagnose Alzheimer Disease.
    JAMA. 2022;327:2281.
    PubMed        
    
    

    
    Nat Rev Neurosci

40. YATES D
    Restoring the aged brain with CSF.
    Nat Rev Neurosci. 2022;23:393.
    PubMed        
    
    

    
    Neurobiol Aging

41. KHAIRE AS, Wimberly CE, Semmes EC, Hurst JH, et al
    An integrated genome and phenome-wide association study approach to understanding Alzheimer's disease predisposition.
    Neurobiol Aging. 2022 May 27. pii: S0197-4580(22)00120.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

42. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    PubMed         Abstract available
    
    
43. MEHTA NH, Suss RA, Dyke JP, Theise ND, et al
    Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease.
    Neurobiol Dis. 2022;170:105776.
    PubMed         Abstract available
    
    
44. RAMAMOORTHY K, Yoshimura R, Al-Juburi S, Anandam KY, et al
    Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation.
    Neurobiol Dis. 2022 Jun 21:105799. doi: 10.1016/j.nbd.2022.105799.
    PubMed         Abstract available
    
    

    
    Neurology

45. MONTINE TJ, Corrada MM, Kawas C, Bukhari S, et al
    Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200832.
    PubMed         Abstract available
    
    

    
    Neuropsychology

46. WRIGHT LM, De Marco M, Venneri A
    Verbal fluency discrepancies as a marker of the prehippocampal stages of Alzheimer's disease.
    Neuropsychology. 2022 Jun 23. pii: 2022-74638-001. doi: 10.1037/neu0000836.
    PubMed         Abstract available
    
    

    
    PLoS One

47. ZAMANI J, Sadr A, Javadi AH
    Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2022;17:e0267608.
    PubMed         Abstract available
    
    
48. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. TAYLOR JL, Pritchard HAT, Walsh KR, Strangward P, et al
    Functionally linked potassium channel activity in cerebral endothelial and smooth muscle cells is compromised in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2022;119:e2204581119.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: